Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen Secures First-Round Patent Win For Tecfidera; One More To Go

Related Content

Patent Challenges Via IPR Still Pretty Scary, Even After Acorda's Win

Aug 26 2015

Biogen CEO Pick Vounatsos Suggests A Return To Commercial Focus

Dec 20 2016

Acorda Defeats Kyle Bass, Now Awaits Ruling In Ampyra ANDA Litigation

Mar 10 2017

Biogen Pays $1.25bn For Peace Of Mind Over Tecfidera, But Legal Wrangling Continues

Jan 18 2017

Biogen Forecasts Gradual Launch For Life-Transforming Drug Spinraza

Jan 26 2017

Related Companies

Biogen, Inc.

Forward Pharma A/S

Acorda Therapeutics, Inc.

Additional Topics

Intellectual Property Legal Issues Regulation BioPharmaceutical

More from Legal & IP

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window